|
| 1 |
A systematic review and meta-analysis comparing everolimus and calcineurin inhibitors (CNIs) to mycophenolate and CNIs in kidney transplant patients
Larraine Vergara-Rejante, Kristel K. Tanhui, Maria Kristina L. Alolod
|
|
| 2 |
Comparison of the Effectiveness and Clinical Outcome of Everolimus Followed by CDK4/6 Inhibitors with the Opposite Treatment Sequence in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer
Hyehyun Jeong, Jae Ho Jeong, Jeong Eun Kim, Jin-Hee Ahn, Kyung Hae Jung, Sung-Bae Kim
Cancer Res Treat.2022;54(2):469-477. Published online 2021 June 23
DOI: http://dx.doi.org/10.4143/crt.2021.205
|
|
| 3 |
Immunosuppressive Drug Measurement by Liquid Chromatography Coupled to Tandem Mass Spectrometry: Interlaboratory Comparison in the Korean Clinical Laboratories
Hyun-Ki Kim, Hyung-Doo Park, Sang-Guk Lee, Hyojin Chae, Sang Hoon Song, Yong-Wha Lee, Yeo-Min Yun, Sunhyun Ahn, Serim Kim, Sun Min Lee, Soo-Youn Lee, Sail Chun
|
|
| 4 |
Systemic Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors in Korea: Literature Review and Expert Opinion
Changhoon Yoo, Chung Ryul Oh, Seung-Tae Kim, Woo Kyun Bae, Hye-Jin Choi, Do-Youn Oh, Myung-Ah Lee, Baek-Yeol Ryoo
Cancer Res Treat.2021;53(2):291-300. Published online 2020 December 29
DOI: http://dx.doi.org/10.4143/crt.2020.1233
|
|
| 5 |
Effect of everolimus rescue therapy for acute cellular rejection following pediatric living donor liver transplantation: Report of one case
Shin Hwang, Jung-Man Namgoong, Seak Hee Oh, Kyung Mo Kim, Chul-Soo Ahn, Hyunhee Kwon, Yu Jeong Cho, Yong Jae Kwon
|
|
| 6 |
Cross-sectional analysis of immunosuppressive regimens focused on everolimus after liver transplantation in a Korean high-volume transplantation center
Sang-Hyun Kang, Shin Hwang, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Chul-Soo Ahn, Deok-Bog Moon, Ki-Hun Kim, Gil-Chun Park, Young-In Yoon, Yo-Han Park, Hui-Dong Cho, Jae-Hyun Kwon, Yong-Kyu Chung, Jin Uk Choi, Sung-Gyu Lee
|
|
| 7 |
A cross-sectional analysis of long-term immunosuppressive regimens after liver transplantation at Asan Medical Center: Increased preference for mycophenolate mofetil
Shin Hwang, Chul-Soo Ahn, Ki-Hun Kim, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Gil-Chun Park, Sung-Gyu Lee
|
|
| 8 |
Biomarkers of Everolimus Sensitivity in Hormone Receptor-Positive Breast Cancer
Zongbi Yi, Fei Ma
J Breast Cancer.2017;20(4):321-326. Published online 2017 December 19
DOI: http://dx.doi.org/10.4048/jbc.2017.20.4.321
|
|
| 9 |
Assessing the role of everolimus in reducing hepatocellular carcinoma recurrence after living donor liver transplantation for patients within the UCSF criteria: re-inventing the role of mammalian target of rapamycin inhibitors
Ashok Thorat, Long-Bin Jeng, Horng-Ren Yang, Chun-Chieh Yeh, Shih-Chao Hsu, Te-Hung Chen, Kin-Shing Poon
|
|
| 10 |
Everolimus Plus Ku0063794 Regimen Promotes Anticancer Effects against Hepatocellular Carcinoma Cells through the Paradoxical Inhibition of Autophagy
Sang Chul Lee, Kee-Hwan Kim, Ok-Hee Kim, Sang Kuon Lee, Ha-Eun Hong, Byung Jo Choi, Wonjun Jeong, Say-June Kim
Cancer Res Treat.2018;50(3):1023-1038. Published online 2017 November 9
DOI: http://dx.doi.org/10.4143/crt.2017.085
|
|
| 11 |
Crizotinib in Combination with Everolimus Synergistically Inhibits Proliferation of Anaplastic Lymphoma Kinase‒Positive Anaplastic Large Cell Lymphoma
Wendan Xu, Ji-Won Kim, Woo June Jung, Youngil Koh, Sung-Soo Yoon
Cancer Res Treat.2018;50(2):599-613. Published online 2017 June 19
DOI: http://dx.doi.org/10.4143/crt.2016.357
|
|
| 12 |
Efficacy and Safety of Everolimus in Korean Patients with Metastatic Renal Cell Carcinoma Following Treatment Failure with a Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor
Kwonoh Park, Jae-Lyun Lee, Jin-Hee Ahn, Kyoo Hyung Lee, In-Gab Jeong, Cheryn Song, Bumsik Hong, Jun Hyuk Hong, Hanjong Ahn
Cancer Res Treat.2014;46(4):339-347. Published online 2014 July 16
DOI: http://dx.doi.org/10.4143/crt.2013.154
|
|
| 13 |
A Prospective, Randomized Comparison of Promus Everolimus-Eluting and TAXUS Liberte Paclitaxel-Eluting Stent Systems in Patients with Coronary Artery Disease Eligible for Percutaneous Coronary Intervention: The PROMISE Study
Ung Kim, Chan-Hee Lee, Jung-Hwan Jo, Hyun-Wook Lee, Yoon-Jung Choi, Jang-Won Son, Sang-Hee Lee, Jong-Seon Park, Dong-Gu Shin, Young-Jo Kim, Myung-Ho Jeong, Myung-Chan Cho, Jang-Ho Bae, Jae-Hwan Lee, Tae-Soo Kang, Kyung-Tae Jung, Kyung-Ho Jung, Seung-Wook Lee, Jang-Hyun Cho, Won Kim, Seung-Ho Hur, Ki-Sik Kim, Heon-Sik Park, Moo-Hyun Kim, Jin-Yong Hwang, Doo-Il Kim, Tae-Ik Kim
|
|
| 14 |
Safety and Efficacy of the Early Introduction of Everolimus (Certican®) with Low Dose of Cyclosporine in de Novo Kidney Recipients after 1 Month of Transplantation (Preliminary Results)
Chang-Kwon Oh, Jong Won Ha, Yeong Hoon Kim, Yong-Lim Kim, Yu Seun Kim
|
|
| 15 |
Oral Everolimus Reduces Adventitial Cell Activation and Neointima Formation in Balloon-Injured Rat Carotid Artery
Keon Woong Moon, Jong Min Lee, Kiyuk Chang, Ki Dong Yoo, Doo Soo Jeon, Ho Joong Youn, Wook Sung Chung, Man Young Lee, Jong Jin Kim, Ki Bae Seung, Chul Min Kim, Soon Jo Hong
Korean Circ J.2004;34(10):983-991. Published online 2004 October 31
DOI: http://dx.doi.org/10.4070/kcj.2004.34.10.983
|
|
